Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1 (MIDAS)

This study has been completed.
Sponsor:
Collaborators:
Pfizer
Tibotec, Inc
Information provided by (Responsible Party):
Babafemi Taiwo, Northwestern University
ClinicalTrials.gov Identifier:
NCT00993148
First received: October 8, 2009
Last updated: April 29, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)